Hygeia Healthcare Holdings Management
Management criteria checks 3/4
Hygeia Healthcare Holdings' CEO is Yiwen Zhu, appointed in Aug 2021, has a tenure of 2.75 years. total yearly compensation is CN¥3.73M, comprised of 13.2% salary and 86.8% bonuses, including company stock and options. directly owns 44.38% of the company’s shares, worth HK$10.37B. The average tenure of the management team and the board of directors is 3.3 years and 4.5 years respectively.
Key information
Yiwen Zhu
Chief executive officer
CN¥3.7m
Total compensation
CEO salary percentage | 13.2% |
CEO tenure | 2.8yrs |
CEO ownership | 44.4% |
Management average tenure | 3.3yrs |
Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CN¥683m |
Sep 30 2023 | n/a | n/a | CN¥635m |
Jun 30 2023 | n/a | n/a | CN¥587m |
Mar 31 2023 | n/a | n/a | CN¥532m |
Dec 31 2022 | CN¥4m | CN¥492k | CN¥477m |
Sep 30 2022 | n/a | n/a | CN¥472m |
Jun 30 2022 | n/a | n/a | CN¥468m |
Mar 31 2022 | n/a | n/a | CN¥455m |
Dec 31 2021 | CN¥709k | CN¥239k | CN¥441m |
Sep 30 2021 | n/a | n/a | CN¥403m |
Jun 30 2021 | n/a | n/a | CN¥365m |
Mar 31 2021 | n/a | n/a | CN¥268m |
Dec 31 2020 | CN¥45k | CN¥37k | CN¥170m |
Sep 30 2020 | n/a | n/a | CN¥100m |
Jun 30 2020 | n/a | n/a | CN¥29m |
Mar 31 2020 | n/a | n/a | CN¥35m |
Dec 31 2019 | CN¥779k | CN¥684k | CN¥40m |
Compensation vs Market: Yiwen's total compensation ($USD514.96K) is about average for companies of similar size in the Hong Kong market ($USD575.18K).
Compensation vs Earnings: Yiwen's compensation has increased by more than 20% in the past year.
CEO
Yiwen Zhu (59 yo)
2.8yrs
Tenure
CN¥3,728,000
Compensation
Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Co-CEO | 2.8yrs | CN¥3.73m | 44.38% CN¥ 10.4b | |
Co-CEO & Executive Director | 2.8yrs | CN¥2.42m | no data | |
Director of Research & Development | 4.3yrs | CN¥1.39m | 0.0051% CN¥ 1.2m | |
Director of Radiotherapy Division & Executive Director | 3.4yrs | CN¥1.55m | no data | |
Joint Company Secretary | no data | CN¥2.84m | 0.45% CN¥ 105.6m | |
Financial Director | no data | no data | no data | |
Joint Company Secretary | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
41yo
Average Age
Experienced Management: 6078's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Co-CEO | 3.2yrs | CN¥3.73m | 44.38% CN¥ 10.4b | |
Co-CEO & Executive Director | 4.9yrs | CN¥2.42m | no data | |
Director of Research & Development | 4.3yrs | CN¥1.39m | 0.0051% CN¥ 1.2m | |
Director of Radiotherapy Division & Executive Director | 3.4yrs | CN¥1.55m | no data | |
Joint Company Secretary | 5.7yrs | CN¥2.84m | 0.45% CN¥ 105.6m | |
Independent Non-Executive Director | 4.7yrs | CN¥240.00k | no data | |
Independent Non-Executive Director | 2yrs | CN¥157.00k | no data | |
Independent Non-Executive Director | 4.7yrs | CN¥240.00k | no data |
4.5yrs
Average Tenure
50yo
Average Age
Experienced Board: 6078's board of directors are considered experienced (4.5 years average tenure).